PMA

P940011: COHERENT PDL1 AND PDL2 LAMBDA PLUS PHOTODYNAMIC LASERS

FDA PMA · System, laser, photodynamic therapy · Lumenis, Inc.

Key facts

PMA number P940011
Trade name COHERENT PDL1 AND PDL2 LAMBDA PLUS PHOTODYNAMIC LASERS
Generic name System, laser, photodynamic therapy
Applicant Lumenis, Inc.
Owner/operator Boston Scientific Corporation
Product code MVF
Approval date Dec 27, 1995
Docket number 97M-0204
Establishment registration 3004135191
FEI number 3004135191

At a glance

  • 1–9 Supplements
  • Dec 23, 1998 Latest supplement decision
  • Yes Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals